TrialJAMA pediatrics2018

Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.

Nicholas Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.